August 2026

Conceptual illustration representing GLP-1 medication hair loss from Ozempic and Wegovy, showing delicate floating hair strands
HairLoss

GLP-1 Medication Hair Loss: Ozempic, Wegovy, and What the 2026 BMJ Study Reveals

A landmark July 2026 BMJ study of nearly 40,000 patients confirms GLP-1 medication hair loss is a clinically validated concern, with Ozempic and Wegovy users facing a 37% higher alopecia risk. Understanding whether you’re experiencing temporary telogen effluvium or permanent androgenetic alopecia is critical. This guide breaks down the mechanisms, your personal risk factors, and exactly when to seek treatment.

Conceptual illustration showing healthy versus compromised hair graft roots, representing hair transplant alcohol and smoking effects on results
HairLoss

Hair Transplant Alcohol and Smoking Effects on Results: The Graft Survival Science Explained

Smoking and alcohol don’t just bend the rules after a hair transplant—they directly compromise graft survival at a biological level. This guide breaks down the molecular science behind nicotine and alcohol’s impact, from vascular disruption to shock loss. If you’re planning a transplant, understanding these risks could be the difference between a 92% and 98% survival rate.

Man with restored natural temple hairline illustrating hair transplant for receding temples step by step results
HairLoss

Hair Transplant for Receding Temples Step by Step: The Temporal Zone Surgical Blueprint

Temple recession is the most technically demanding zone of the scalp to restore—and it requires a completely different surgical approach than a standard hairline procedure. This guide breaks down hair transplant for receding temples step by step, covering the biology, incision angles, and artistry behind natural-looking results. Written at surgeon-level depth for patients who want to truly understand the procedure.

Scroll to Top